Understanding Mullerian Anomalies in Women
Diagnostic, Therapeutic and Reproductive Aspects of Patients With Mullerian Anomalies: a Retrospective Cohort
University Hospital, Ghent · NCT04732546
This study is trying to learn more about rare reproductive system conditions in women to see how better diagnosis and less invasive surgeries can help improve their fertility and overall health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | N/A to 45 Years |
| Sex | Female |
| Sponsor | University Hospital, Ghent (other) |
| Locations | 1 site (Ghent, East Flanders) |
| Trial ID | NCT04732546 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance the understanding of Mullerian anomalies, which are rare congenital conditions affecting the female reproductive system. It focuses on identifying the clinical implications, including reproductive issues and obstetric complications, associated with these anomalies. The study will evaluate the effectiveness of improved diagnostic tools and minimally invasive surgical treatments to preserve and potentially enhance fertility in affected women. By gathering data from women with these conditions, the study seeks to provide insights that could lead to better management and outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are women under 45 years of age who have a uterus and a diagnosed Mullerian anomaly.
Not a fit: Patients over the age of 45 or those without a uterus will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and treatment options for women with Mullerian anomalies, enhancing their reproductive health.
How similar studies have performed: While Mullerian anomalies are rare and not extensively studied, there is potential for success based on improved diagnostic and surgical techniques used in similar conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * women with a uterus * presence of a mullerian variation * Maximum age 45y Exclusion Criteria: * women without a uterus * aged \>45y
Where this trial is running
Ghent, East Flanders
- UZ Ghent — Ghent, East Flanders, Belgium (RECRUITING)
Study contacts
- Principal investigator: Tjalina Hamerlynck — University Hospital, Ghent
- Study coordinator: Eline Meireson
- Email: eline.meireson@uzgent.be
- Phone: 093327817
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Mullerian Anomaly of Vagina, Mullerian Anomaly of Uterus, Nec, Mullerian Anomaly of Cervix, Mullerian anomaly, Diagnostic tools, Surgical treatment, Reproductive function, Obstetric complications